Table 2 |
||||||||||||||
| Parents report of ADHD core symptoms (attention, hyperactivity, total score) regarding the treatments (NF, MED, combined) | ||||||||||||||
| Pre treatment | Post treatment | Pre-Post change (T1-T2)1 | Treatment effect2 | |||||||||||
| Barkley rating scores | N | Mean | 95 % CI | N | Mean | 95 % CI | N | Mean3 | 95 % CI | Effect size4 | p-unadj.5 | p-adj.6 | p-uadj.5 | p-adj.6 |
| Total | < .001 | 0,310 | 0.173 | 0,228 | ||||||||||
| Medication | 29 | 34,5 | (30.6, 38.5) | 22 | 27,8 | (24.0, 31.6) | 22 | 7.9 | (4.5, 11.4) | |||||
| Neurofeedback + Medication | 24 | 32,6 | (28.6, 36.6) | 22 | 23,7 | (19.8, 27.6) | 22 | 8,6 | (5.0, 12.2) | 1.76 | ||||
| Neurofeedback | 23 | 37 | (33.9, 40.0) | 19 | 26,7 | (23.4, 30.1) | 19 | 10,7 | (7.6, 13.8) | 2.25 | ||||
| Attention | < .001 | 0,738 | 0,098 | 0,139 | ||||||||||
| Medication | 29 | 15,9 | (13.8, 18.0) | 22 | 15,2 | (13.2, 17.2) | 22 | 1,5 | (-0.3, 3.3) | 0.70 | ||||
| Neurofeedback + Medication | 24 | 15,9 | (13.9, 18.0) | 22 | 14,5 | (12.0, 17.2) | 22 | 1,1 | (-0.7, 3.0) | 0.46 | ||||
| Neurofeedback | 23 | 19,2 | (17.2, 21.1) | 19 | 16,6 | (14.5, 18.7) | 19 | 3,1 | (1.6, 4.5) | 2.08 | ||||
| Hyperactivity | < .001 | 0,077 | 0,101 | 0,186 | ||||||||||
| Medication | 29 | 18,7 | (16.3, 21.0) | 22 | 12,5 | (10.2, 14.4) | 22 | 6,5 | (4.3, 8.6) | 2.45 | ||||
| Neurofeedback + Medication | 24 | 16,7 | (14.3, 19.0) | 22 | 9,1 | (6.8, 11.4) | 22 | 7,5 | (4.9, 10.0) | 1,75 | ||||
| Neurofeedback | 23 | 17,8 | (15.9, 19.6) | 19 | 10,1 | (8.0, 12.2) | 19 | 7,6 | (5.6, 9.6) | 2.88 | ||||
1 Tests for within-subject-contrast in the General linear modell (GLM). 2 Between-groups-effect in the GLM. 3 Mean of the differences, i.e. excluding drop outs at one missing point. 4 Effect size measure δRM (ref Morris). 5 Unadjusted model. 6 Model adjusted for age and sex.
Duric et al. BMC Psychiatry 2012 12:107 doi:10.1186/1471-244X-12-107
